Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats

The treatment of alcoholic liver disease with propylthiouracil is based on its effect of suppressing the ethanol‐induced increase in hepatic oxygen consumption. It has been postulated that liver necrosis ensues when the increase in oxygen demand by the liver exceeds oxygen delivery to this organ. Da...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Md.), 1989-09, Vol.10 (3), p.273-278
Hauptverfasser: Kawasaki, Tsunehisa, Carmichael, Frederick J., Giles, Gwynne, Saldivia, Victor, Israel, Yedy, Orrego, Hector
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 278
container_issue 3
container_start_page 273
container_title Hepatology (Baltimore, Md.)
container_volume 10
creator Kawasaki, Tsunehisa
Carmichael, Frederick J.
Giles, Gwynne
Saldivia, Victor
Israel, Yedy
Orrego, Hector
description The treatment of alcoholic liver disease with propylthiouracil is based on its effect of suppressing the ethanol‐induced increase in hepatic oxygen consumption. It has been postulated that liver necrosis ensues when the increase in oxygen demand by the liver exceeds oxygen delivery to this organ. Data are now presented which show that propylthiouracil also increases portal blood flow in awake, unrestrained rats. Liver blood flow was determined using the labeled microsphere technique in rats at various intervals (0.25, 0.5, 1.0, 3.0, 6.0 and 24 hr) after oral propylthiouracil (50 mg per kg). Administration of propylthiouracil (dose range: 6.25 to 100.0 mg per kg) produced a dose‐dependent increase in portal blood flow when given either orally or intraarterially. Maximal flows were obtained with 50 mg per kg (controls = 37.8 ± 1.5, oral propylthiouracil = 50.7 ± 2.2 ml ± kg−1‐min−1). This increase in portal blood flow was accompanied by a decrease in preportal vascular resistance (controls = 2.61 ± 0.16; propylthiouracil, 50 mg per kg = 1.79 ± 0.09 mmHg per ml ± kg−1 ± min−1). These effects were correlated with the plasma concentrations of propylthiouracil (r = 0.67, n = 68, p ⩽ 0.001). The effect of oral propylthiouracil (50 mg per kg) on portal blood flow started at 0.5 hr and lasted for 6 hr after administration, whereas total liver blood flow was increased for 3 hr. Oral propylthiouracil (50 mg per kg) for 5 days resulted in a 53% increase in thyroid weight, an 85% reduction in 125I thyroid uptake and a 74% decrease in serum thyroxine concentration. This treatment, however, did not modify portal blood flow, nor the response to acute propylthiouracil. Oral administration of equipotent doses of another antithyroid drug, methimazole (10 and 20 mg per kg), had no effect on portal blood flow. Because of the rapid increase in portal blood flow following a single oral or parenteral dose of propylthiouracil and the lack of effect of methimazole, it is concluded that this response of propylthiouracil is independent of its effect on the thyroid gland and of intestinal absorption. The increase in portal blood flow can contribute to the protective effect of propylthiouracil against alcohol‐induced liver necrosis by increasing oxygen delivery to the liver.
doi_str_mv 10.1002/hep.1840100303
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79136637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79136637</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3803-52213198597512f2efe46103d7794951a8d72cc4833ad31929771fca869d7c2a3</originalsourceid><addsrcrecordid>eNqFkL1PwzAQxS0EKqWwsiF5YkvxRxzHI6oKRUKCAebIOGclkMTBTlSFvx5DK2BjOt3du6d3P4TOKVlSQthVBf2S5imJDSf8AM2pYDLhXJBDNCdMkkRRro7RSQivhBCVsnyGZkwKJVIxR7C2FswQsLO4966fmqGq3ei1qRusuxK3EAet_nANYNfh0De6M1VXG1xB68qp021tAq47rLf6Db5vxs5DGLyuOyix10M4RUdWNwHO9nWBnm_WT6tNcv9we7e6vk8MzwlPBGOUU5ULJQVlloGFNKOEl1KqVAmq81IyY9Kcc11GIVNSUmt0nqlSGqb5Al3ufOMr72PMULR1MNDEzODGUMjIIsu4jMLlTmi8C8GDLXofv_RTQUnxxbWIXItfrvHgYu88vrRQ_sj3IONe7fbbuoHpH7dis3784_0JIZaEbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79136637</pqid></control><display><type>article</type><title>Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Kawasaki, Tsunehisa ; Carmichael, Frederick J. ; Giles, Gwynne ; Saldivia, Victor ; Israel, Yedy ; Orrego, Hector</creator><creatorcontrib>Kawasaki, Tsunehisa ; Carmichael, Frederick J. ; Giles, Gwynne ; Saldivia, Victor ; Israel, Yedy ; Orrego, Hector</creatorcontrib><description>The treatment of alcoholic liver disease with propylthiouracil is based on its effect of suppressing the ethanol‐induced increase in hepatic oxygen consumption. It has been postulated that liver necrosis ensues when the increase in oxygen demand by the liver exceeds oxygen delivery to this organ. Data are now presented which show that propylthiouracil also increases portal blood flow in awake, unrestrained rats. Liver blood flow was determined using the labeled microsphere technique in rats at various intervals (0.25, 0.5, 1.0, 3.0, 6.0 and 24 hr) after oral propylthiouracil (50 mg per kg). Administration of propylthiouracil (dose range: 6.25 to 100.0 mg per kg) produced a dose‐dependent increase in portal blood flow when given either orally or intraarterially. Maximal flows were obtained with 50 mg per kg (controls = 37.8 ± 1.5, oral propylthiouracil = 50.7 ± 2.2 ml ± kg−1‐min−1). This increase in portal blood flow was accompanied by a decrease in preportal vascular resistance (controls = 2.61 ± 0.16; propylthiouracil, 50 mg per kg = 1.79 ± 0.09 mmHg per ml ± kg−1 ± min−1). These effects were correlated with the plasma concentrations of propylthiouracil (r = 0.67, n = 68, p ⩽ 0.001). The effect of oral propylthiouracil (50 mg per kg) on portal blood flow started at 0.5 hr and lasted for 6 hr after administration, whereas total liver blood flow was increased for 3 hr. Oral propylthiouracil (50 mg per kg) for 5 days resulted in a 53% increase in thyroid weight, an 85% reduction in 125I thyroid uptake and a 74% decrease in serum thyroxine concentration. This treatment, however, did not modify portal blood flow, nor the response to acute propylthiouracil. Oral administration of equipotent doses of another antithyroid drug, methimazole (10 and 20 mg per kg), had no effect on portal blood flow. Because of the rapid increase in portal blood flow following a single oral or parenteral dose of propylthiouracil and the lack of effect of methimazole, it is concluded that this response of propylthiouracil is independent of its effect on the thyroid gland and of intestinal absorption. The increase in portal blood flow can contribute to the protective effect of propylthiouracil against alcohol‐induced liver necrosis by increasing oxygen delivery to the liver.</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.1840100303</identifier><identifier>PMID: 2759545</identifier><language>eng</language><publisher>Philadelphia, PA: W.B. Saunders</publisher><subject>Animals ; Drug Administration Schedule ; Ethanol - pharmacology ; Hemodynamics - drug effects ; Liver Circulation - drug effects ; Male ; Methimazole - pharmacology ; Propylthiouracil - pharmacology ; Rats ; Rats, Inbred Strains ; Thyroxine - blood ; Vascular Resistance - drug effects</subject><ispartof>Hepatology (Baltimore, Md.), 1989-09, Vol.10 (3), p.273-278</ispartof><rights>Copyright © 1989 American Association for the Study of Liver Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3803-52213198597512f2efe46103d7794951a8d72cc4833ad31929771fca869d7c2a3</citedby><cites>FETCH-LOGICAL-c3803-52213198597512f2efe46103d7794951a8d72cc4833ad31929771fca869d7c2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.1840100303$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.1840100303$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2759545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawasaki, Tsunehisa</creatorcontrib><creatorcontrib>Carmichael, Frederick J.</creatorcontrib><creatorcontrib>Giles, Gwynne</creatorcontrib><creatorcontrib>Saldivia, Victor</creatorcontrib><creatorcontrib>Israel, Yedy</creatorcontrib><creatorcontrib>Orrego, Hector</creatorcontrib><title>Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>The treatment of alcoholic liver disease with propylthiouracil is based on its effect of suppressing the ethanol‐induced increase in hepatic oxygen consumption. It has been postulated that liver necrosis ensues when the increase in oxygen demand by the liver exceeds oxygen delivery to this organ. Data are now presented which show that propylthiouracil also increases portal blood flow in awake, unrestrained rats. Liver blood flow was determined using the labeled microsphere technique in rats at various intervals (0.25, 0.5, 1.0, 3.0, 6.0 and 24 hr) after oral propylthiouracil (50 mg per kg). Administration of propylthiouracil (dose range: 6.25 to 100.0 mg per kg) produced a dose‐dependent increase in portal blood flow when given either orally or intraarterially. Maximal flows were obtained with 50 mg per kg (controls = 37.8 ± 1.5, oral propylthiouracil = 50.7 ± 2.2 ml ± kg−1‐min−1). This increase in portal blood flow was accompanied by a decrease in preportal vascular resistance (controls = 2.61 ± 0.16; propylthiouracil, 50 mg per kg = 1.79 ± 0.09 mmHg per ml ± kg−1 ± min−1). These effects were correlated with the plasma concentrations of propylthiouracil (r = 0.67, n = 68, p ⩽ 0.001). The effect of oral propylthiouracil (50 mg per kg) on portal blood flow started at 0.5 hr and lasted for 6 hr after administration, whereas total liver blood flow was increased for 3 hr. Oral propylthiouracil (50 mg per kg) for 5 days resulted in a 53% increase in thyroid weight, an 85% reduction in 125I thyroid uptake and a 74% decrease in serum thyroxine concentration. This treatment, however, did not modify portal blood flow, nor the response to acute propylthiouracil. Oral administration of equipotent doses of another antithyroid drug, methimazole (10 and 20 mg per kg), had no effect on portal blood flow. Because of the rapid increase in portal blood flow following a single oral or parenteral dose of propylthiouracil and the lack of effect of methimazole, it is concluded that this response of propylthiouracil is independent of its effect on the thyroid gland and of intestinal absorption. The increase in portal blood flow can contribute to the protective effect of propylthiouracil against alcohol‐induced liver necrosis by increasing oxygen delivery to the liver.</description><subject>Animals</subject><subject>Drug Administration Schedule</subject><subject>Ethanol - pharmacology</subject><subject>Hemodynamics - drug effects</subject><subject>Liver Circulation - drug effects</subject><subject>Male</subject><subject>Methimazole - pharmacology</subject><subject>Propylthiouracil - pharmacology</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Thyroxine - blood</subject><subject>Vascular Resistance - drug effects</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkL1PwzAQxS0EKqWwsiF5YkvxRxzHI6oKRUKCAebIOGclkMTBTlSFvx5DK2BjOt3du6d3P4TOKVlSQthVBf2S5imJDSf8AM2pYDLhXJBDNCdMkkRRro7RSQivhBCVsnyGZkwKJVIxR7C2FswQsLO4966fmqGq3ei1qRusuxK3EAet_nANYNfh0De6M1VXG1xB68qp021tAq47rLf6Db5vxs5DGLyuOyix10M4RUdWNwHO9nWBnm_WT6tNcv9we7e6vk8MzwlPBGOUU5ULJQVlloGFNKOEl1KqVAmq81IyY9Kcc11GIVNSUmt0nqlSGqb5Al3ufOMr72PMULR1MNDEzODGUMjIIsu4jMLlTmi8C8GDLXofv_RTQUnxxbWIXItfrvHgYu88vrRQ_sj3IONe7fbbuoHpH7dis3784_0JIZaEbg</recordid><startdate>198909</startdate><enddate>198909</enddate><creator>Kawasaki, Tsunehisa</creator><creator>Carmichael, Frederick J.</creator><creator>Giles, Gwynne</creator><creator>Saldivia, Victor</creator><creator>Israel, Yedy</creator><creator>Orrego, Hector</creator><general>W.B. Saunders</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198909</creationdate><title>Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats</title><author>Kawasaki, Tsunehisa ; Carmichael, Frederick J. ; Giles, Gwynne ; Saldivia, Victor ; Israel, Yedy ; Orrego, Hector</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3803-52213198597512f2efe46103d7794951a8d72cc4833ad31929771fca869d7c2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>Drug Administration Schedule</topic><topic>Ethanol - pharmacology</topic><topic>Hemodynamics - drug effects</topic><topic>Liver Circulation - drug effects</topic><topic>Male</topic><topic>Methimazole - pharmacology</topic><topic>Propylthiouracil - pharmacology</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Thyroxine - blood</topic><topic>Vascular Resistance - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawasaki, Tsunehisa</creatorcontrib><creatorcontrib>Carmichael, Frederick J.</creatorcontrib><creatorcontrib>Giles, Gwynne</creatorcontrib><creatorcontrib>Saldivia, Victor</creatorcontrib><creatorcontrib>Israel, Yedy</creatorcontrib><creatorcontrib>Orrego, Hector</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawasaki, Tsunehisa</au><au>Carmichael, Frederick J.</au><au>Giles, Gwynne</au><au>Saldivia, Victor</au><au>Israel, Yedy</au><au>Orrego, Hector</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>1989-09</date><risdate>1989</risdate><volume>10</volume><issue>3</issue><spage>273</spage><epage>278</epage><pages>273-278</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><abstract>The treatment of alcoholic liver disease with propylthiouracil is based on its effect of suppressing the ethanol‐induced increase in hepatic oxygen consumption. It has been postulated that liver necrosis ensues when the increase in oxygen demand by the liver exceeds oxygen delivery to this organ. Data are now presented which show that propylthiouracil also increases portal blood flow in awake, unrestrained rats. Liver blood flow was determined using the labeled microsphere technique in rats at various intervals (0.25, 0.5, 1.0, 3.0, 6.0 and 24 hr) after oral propylthiouracil (50 mg per kg). Administration of propylthiouracil (dose range: 6.25 to 100.0 mg per kg) produced a dose‐dependent increase in portal blood flow when given either orally or intraarterially. Maximal flows were obtained with 50 mg per kg (controls = 37.8 ± 1.5, oral propylthiouracil = 50.7 ± 2.2 ml ± kg−1‐min−1). This increase in portal blood flow was accompanied by a decrease in preportal vascular resistance (controls = 2.61 ± 0.16; propylthiouracil, 50 mg per kg = 1.79 ± 0.09 mmHg per ml ± kg−1 ± min−1). These effects were correlated with the plasma concentrations of propylthiouracil (r = 0.67, n = 68, p ⩽ 0.001). The effect of oral propylthiouracil (50 mg per kg) on portal blood flow started at 0.5 hr and lasted for 6 hr after administration, whereas total liver blood flow was increased for 3 hr. Oral propylthiouracil (50 mg per kg) for 5 days resulted in a 53% increase in thyroid weight, an 85% reduction in 125I thyroid uptake and a 74% decrease in serum thyroxine concentration. This treatment, however, did not modify portal blood flow, nor the response to acute propylthiouracil. Oral administration of equipotent doses of another antithyroid drug, methimazole (10 and 20 mg per kg), had no effect on portal blood flow. Because of the rapid increase in portal blood flow following a single oral or parenteral dose of propylthiouracil and the lack of effect of methimazole, it is concluded that this response of propylthiouracil is independent of its effect on the thyroid gland and of intestinal absorption. The increase in portal blood flow can contribute to the protective effect of propylthiouracil against alcohol‐induced liver necrosis by increasing oxygen delivery to the liver.</abstract><cop>Philadelphia, PA</cop><pub>W.B. Saunders</pub><pmid>2759545</pmid><doi>10.1002/hep.1840100303</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-9139
ispartof Hepatology (Baltimore, Md.), 1989-09, Vol.10 (3), p.273-278
issn 0270-9139
1527-3350
language eng
recordid cdi_proquest_miscellaneous_79136637
source MEDLINE; Wiley Online Library All Journals
subjects Animals
Drug Administration Schedule
Ethanol - pharmacology
Hemodynamics - drug effects
Liver Circulation - drug effects
Male
Methimazole - pharmacology
Propylthiouracil - pharmacology
Rats
Rats, Inbred Strains
Thyroxine - blood
Vascular Resistance - drug effects
title Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T09%3A52%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20propylthiouracil%20and%20methimazole%20on%20splanchnic%20hemodynamics%20in%20awake%20and%20unrestrained%20rats&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Kawasaki,%20Tsunehisa&rft.date=1989-09&rft.volume=10&rft.issue=3&rft.spage=273&rft.epage=278&rft.pages=273-278&rft.issn=0270-9139&rft.eissn=1527-3350&rft_id=info:doi/10.1002/hep.1840100303&rft_dat=%3Cproquest_cross%3E79136637%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79136637&rft_id=info:pmid/2759545&rfr_iscdi=true